Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $217,210.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 14,500 shares of the stock in a transaction on Friday, January 24th. The stock was sold at an average price of $14.98, for a total value of $217,210.00. Following the transaction, the insider now owns 295,444 shares in the company, valued at $4,425,751.12. The trade was a 4.68 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Hakan Kardes also recently made the following trade(s):

• On Tuesday, January 21st, Hakan Kardes sold 10,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.99, for a total value of $157,395.00.
• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.80, for a total value of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.98, for a total value of $58,410.00.

Alignment Healthcare Stock Up 2.7 %

NASDAQ:ALHC traded up $0.40 on Friday, hitting $14.97. The stock had a trading volume of 2,062,404 shares, compared to its average volume of 1,865,740. The stock has a market cap of $2.87 billion, a P/E ratio of -19.44 and a beta of 1.45. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $15.05. The firm’s fifty day simple moving average is $12.13 and its two-hundred day simple moving average is $10.99.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting the consensus estimate of ($0.14). The company had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The firm’s revenue for the quarter was up 51.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.19) EPS. Analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently modified their holdings of the company. R Squared Ltd bought a new position in Alignment Healthcare in the 4th quarter valued at $55,000. nVerses Capital LLC purchased a new stake in shares of Alignment Healthcare in the 3rd quarter valued at about $95,000. Ballentine Partners LLC bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $121,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Alignment Healthcare during the third quarter worth about $131,000. Finally, Creative Planning raised its stake in Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after purchasing an additional 2,072 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ALHC has been the topic of a number of recent analyst reports. Stifel Nicolaus boosted their price target on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. UBS Group boosted their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 2nd. Barclays boosted their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Finally, KeyCorp initiated coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.